A biopharmaceutical company focused on addressing unmet needs in the fields of severe burns and other hard-to-heal wounds and a second biopharmaceutical company focused on developing novel solutions for the treatment of specialty cancers and urological diseases make up two of the three stocks highlighted in today’s article where analysts at Oppenheimer see triple-digit upside potential. For more on these three stocks, CLICK HERE.